Loading…
A novel antioxidant agent caffeic acid phenethyl ester prevents shock wave-induced renal tubular oxidative stress
The aim of this study was to evaluate the effects of the novel free radical scavenger caffeic acid phenethyl ester (CAPE) on extracorporeal shock wave lithotripsy (ESWL) induced renal impairment. The study was performed using 30 rabbits which were divided into two groups, each exposed to 3,000 shock...
Saved in:
Published in: | Urolithiasis 2005-06, Vol.33 (3), p.239-243 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c326t-3de9676d72e8a8c5a1c5f1af2b7d2c87226867531c7a7002f00d6fec2299c1803 |
---|---|
cites | cdi_FETCH-LOGICAL-c326t-3de9676d72e8a8c5a1c5f1af2b7d2c87226867531c7a7002f00d6fec2299c1803 |
container_end_page | 243 |
container_issue | 3 |
container_start_page | 239 |
container_title | Urolithiasis |
container_volume | 33 |
creator | Ozguner, Fehmi Armagan, Abdullah Koyu, Ahmet Caliskan, Sadettin Koylu, Halis |
description | The aim of this study was to evaluate the effects of the novel free radical scavenger caffeic acid phenethyl ester (CAPE) on extracorporeal shock wave lithotripsy (ESWL) induced renal impairment. The study was performed using 30 rabbits which were divided into two groups, each exposed to 3,000 shock waves at 18 kV: (1) control group, (2) ESWL+CAPE treated group. Malodialdehyde (MDA), urine N-acetyl-beta-glucosaminidase (NAG) activity, uric acid and white cell counts were used as markers of oxidative stress. Following shock wave exposure there was a significant rise in MDA, NAG and uric acid and white cell counts. CAPE reduced the rise in MDA, NAG, uric acid and white cell counts. Thus CAPE treatment to a great extent prevented the induction of these renal changes. Our results suggest that the antioxidant capacity of the kidney tissue was reduced after ESWL treatment and that the tissue was exposed to oxidant stress. We conclude that CAPE treatment provided significant protection against ESWL induced free radical damage. |
doi_str_mv | 10.1007/s00240-005-0470-x |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67970163</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2428279731</sourcerecordid><originalsourceid>FETCH-LOGICAL-c326t-3de9676d72e8a8c5a1c5f1af2b7d2c87226867531c7a7002f00d6fec2299c1803</originalsourceid><addsrcrecordid>eNpdkUtPwzAQhC0EgvL4AVyQxYGbYW0ntnNEiJeExAXOlmtvaCBNip2U8u9xaSUkLruXb0ezM4SccrjkAPoqAYgCGEDJoNDAVjtkwgtZMDC62iUTkACsVEIekMOU3gG4VpXYJwe8NFoLUUzI5zXt-iW21HVD06-akDd1b5ind3WNjafON4EuZtjhMPtuKaYBI11EXGYo0TTr_Qf9cktkTRdGj4FG7FxLh3E6ti7SX9GhWSJNQ8SUjsle7dqEJ9t9RF7vbl9uHtjT8_3jzfUT81KogcmAldIqaIHGGV867suau1pMdRDeZPfKKF1K7rXTOYcaIKgavRBV5bkBeUQuNrqL2H-O2bWdN8lj27oO-zFZpSsNXMkMnv8D3_sx5heSNabg0shKZ4hvIB_7lCLWdhGbuYvfloNdl2E3Zdhchl2XYVf55mwrPE7nGP4utunLH5p3hnE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>884138397</pqid></control><display><type>article</type><title>A novel antioxidant agent caffeic acid phenethyl ester prevents shock wave-induced renal tubular oxidative stress</title><source>Springer Link</source><creator>Ozguner, Fehmi ; Armagan, Abdullah ; Koyu, Ahmet ; Caliskan, Sadettin ; Koylu, Halis</creator><creatorcontrib>Ozguner, Fehmi ; Armagan, Abdullah ; Koyu, Ahmet ; Caliskan, Sadettin ; Koylu, Halis</creatorcontrib><description>The aim of this study was to evaluate the effects of the novel free radical scavenger caffeic acid phenethyl ester (CAPE) on extracorporeal shock wave lithotripsy (ESWL) induced renal impairment. The study was performed using 30 rabbits which were divided into two groups, each exposed to 3,000 shock waves at 18 kV: (1) control group, (2) ESWL+CAPE treated group. Malodialdehyde (MDA), urine N-acetyl-beta-glucosaminidase (NAG) activity, uric acid and white cell counts were used as markers of oxidative stress. Following shock wave exposure there was a significant rise in MDA, NAG and uric acid and white cell counts. CAPE reduced the rise in MDA, NAG, uric acid and white cell counts. Thus CAPE treatment to a great extent prevented the induction of these renal changes. Our results suggest that the antioxidant capacity of the kidney tissue was reduced after ESWL treatment and that the tissue was exposed to oxidant stress. We conclude that CAPE treatment provided significant protection against ESWL induced free radical damage.</description><identifier>ISSN: 0300-5623</identifier><identifier>ISSN: 2194-7228</identifier><identifier>EISSN: 1434-0879</identifier><identifier>EISSN: 2194-7236</identifier><identifier>DOI: 10.1007/s00240-005-0470-x</identifier><identifier>PMID: 15877224</identifier><language>eng</language><publisher>Germany: Springer Nature B.V</publisher><subject>Acetylglucosaminidase - urine ; Acids ; Animals ; Antioxidants ; Antioxidants - pharmacology ; Caffeic Acids - pharmacology ; Kidney Tubules - metabolism ; Lithotripsy ; Lithotripsy - adverse effects ; Malondialdehyde - urine ; Oxidative stress ; Oxidative Stress - drug effects ; Phenylethyl Alcohol - analogs & derivatives ; Phenylethyl Alcohol - pharmacology ; Rabbits</subject><ispartof>Urolithiasis, 2005-06, Vol.33 (3), p.239-243</ispartof><rights>Springer-Verlag 2005</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c326t-3de9676d72e8a8c5a1c5f1af2b7d2c87226867531c7a7002f00d6fec2299c1803</citedby><cites>FETCH-LOGICAL-c326t-3de9676d72e8a8c5a1c5f1af2b7d2c87226867531c7a7002f00d6fec2299c1803</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15877224$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ozguner, Fehmi</creatorcontrib><creatorcontrib>Armagan, Abdullah</creatorcontrib><creatorcontrib>Koyu, Ahmet</creatorcontrib><creatorcontrib>Caliskan, Sadettin</creatorcontrib><creatorcontrib>Koylu, Halis</creatorcontrib><title>A novel antioxidant agent caffeic acid phenethyl ester prevents shock wave-induced renal tubular oxidative stress</title><title>Urolithiasis</title><addtitle>Urol Res</addtitle><description>The aim of this study was to evaluate the effects of the novel free radical scavenger caffeic acid phenethyl ester (CAPE) on extracorporeal shock wave lithotripsy (ESWL) induced renal impairment. The study was performed using 30 rabbits which were divided into two groups, each exposed to 3,000 shock waves at 18 kV: (1) control group, (2) ESWL+CAPE treated group. Malodialdehyde (MDA), urine N-acetyl-beta-glucosaminidase (NAG) activity, uric acid and white cell counts were used as markers of oxidative stress. Following shock wave exposure there was a significant rise in MDA, NAG and uric acid and white cell counts. CAPE reduced the rise in MDA, NAG, uric acid and white cell counts. Thus CAPE treatment to a great extent prevented the induction of these renal changes. Our results suggest that the antioxidant capacity of the kidney tissue was reduced after ESWL treatment and that the tissue was exposed to oxidant stress. We conclude that CAPE treatment provided significant protection against ESWL induced free radical damage.</description><subject>Acetylglucosaminidase - urine</subject><subject>Acids</subject><subject>Animals</subject><subject>Antioxidants</subject><subject>Antioxidants - pharmacology</subject><subject>Caffeic Acids - pharmacology</subject><subject>Kidney Tubules - metabolism</subject><subject>Lithotripsy</subject><subject>Lithotripsy - adverse effects</subject><subject>Malondialdehyde - urine</subject><subject>Oxidative stress</subject><subject>Oxidative Stress - drug effects</subject><subject>Phenylethyl Alcohol - analogs & derivatives</subject><subject>Phenylethyl Alcohol - pharmacology</subject><subject>Rabbits</subject><issn>0300-5623</issn><issn>2194-7228</issn><issn>1434-0879</issn><issn>2194-7236</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNpdkUtPwzAQhC0EgvL4AVyQxYGbYW0ntnNEiJeExAXOlmtvaCBNip2U8u9xaSUkLruXb0ezM4SccrjkAPoqAYgCGEDJoNDAVjtkwgtZMDC62iUTkACsVEIekMOU3gG4VpXYJwe8NFoLUUzI5zXt-iW21HVD06-akDd1b5ind3WNjafON4EuZtjhMPtuKaYBI11EXGYo0TTr_Qf9cktkTRdGj4FG7FxLh3E6ti7SX9GhWSJNQ8SUjsle7dqEJ9t9RF7vbl9uHtjT8_3jzfUT81KogcmAldIqaIHGGV867suau1pMdRDeZPfKKF1K7rXTOYcaIKgavRBV5bkBeUQuNrqL2H-O2bWdN8lj27oO-zFZpSsNXMkMnv8D3_sx5heSNabg0shKZ4hvIB_7lCLWdhGbuYvfloNdl2E3Zdhchl2XYVf55mwrPE7nGP4utunLH5p3hnE</recordid><startdate>20050601</startdate><enddate>20050601</enddate><creator>Ozguner, Fehmi</creator><creator>Armagan, Abdullah</creator><creator>Koyu, Ahmet</creator><creator>Caliskan, Sadettin</creator><creator>Koylu, Halis</creator><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20050601</creationdate><title>A novel antioxidant agent caffeic acid phenethyl ester prevents shock wave-induced renal tubular oxidative stress</title><author>Ozguner, Fehmi ; Armagan, Abdullah ; Koyu, Ahmet ; Caliskan, Sadettin ; Koylu, Halis</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c326t-3de9676d72e8a8c5a1c5f1af2b7d2c87226867531c7a7002f00d6fec2299c1803</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Acetylglucosaminidase - urine</topic><topic>Acids</topic><topic>Animals</topic><topic>Antioxidants</topic><topic>Antioxidants - pharmacology</topic><topic>Caffeic Acids - pharmacology</topic><topic>Kidney Tubules - metabolism</topic><topic>Lithotripsy</topic><topic>Lithotripsy - adverse effects</topic><topic>Malondialdehyde - urine</topic><topic>Oxidative stress</topic><topic>Oxidative Stress - drug effects</topic><topic>Phenylethyl Alcohol - analogs & derivatives</topic><topic>Phenylethyl Alcohol - pharmacology</topic><topic>Rabbits</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ozguner, Fehmi</creatorcontrib><creatorcontrib>Armagan, Abdullah</creatorcontrib><creatorcontrib>Koyu, Ahmet</creatorcontrib><creatorcontrib>Caliskan, Sadettin</creatorcontrib><creatorcontrib>Koylu, Halis</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medicine (ProQuest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest Health & Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health & Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Urolithiasis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ozguner, Fehmi</au><au>Armagan, Abdullah</au><au>Koyu, Ahmet</au><au>Caliskan, Sadettin</au><au>Koylu, Halis</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A novel antioxidant agent caffeic acid phenethyl ester prevents shock wave-induced renal tubular oxidative stress</atitle><jtitle>Urolithiasis</jtitle><addtitle>Urol Res</addtitle><date>2005-06-01</date><risdate>2005</risdate><volume>33</volume><issue>3</issue><spage>239</spage><epage>243</epage><pages>239-243</pages><issn>0300-5623</issn><issn>2194-7228</issn><eissn>1434-0879</eissn><eissn>2194-7236</eissn><abstract>The aim of this study was to evaluate the effects of the novel free radical scavenger caffeic acid phenethyl ester (CAPE) on extracorporeal shock wave lithotripsy (ESWL) induced renal impairment. The study was performed using 30 rabbits which were divided into two groups, each exposed to 3,000 shock waves at 18 kV: (1) control group, (2) ESWL+CAPE treated group. Malodialdehyde (MDA), urine N-acetyl-beta-glucosaminidase (NAG) activity, uric acid and white cell counts were used as markers of oxidative stress. Following shock wave exposure there was a significant rise in MDA, NAG and uric acid and white cell counts. CAPE reduced the rise in MDA, NAG, uric acid and white cell counts. Thus CAPE treatment to a great extent prevented the induction of these renal changes. Our results suggest that the antioxidant capacity of the kidney tissue was reduced after ESWL treatment and that the tissue was exposed to oxidant stress. We conclude that CAPE treatment provided significant protection against ESWL induced free radical damage.</abstract><cop>Germany</cop><pub>Springer Nature B.V</pub><pmid>15877224</pmid><doi>10.1007/s00240-005-0470-x</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0300-5623 |
ispartof | Urolithiasis, 2005-06, Vol.33 (3), p.239-243 |
issn | 0300-5623 2194-7228 1434-0879 2194-7236 |
language | eng |
recordid | cdi_proquest_miscellaneous_67970163 |
source | Springer Link |
subjects | Acetylglucosaminidase - urine Acids Animals Antioxidants Antioxidants - pharmacology Caffeic Acids - pharmacology Kidney Tubules - metabolism Lithotripsy Lithotripsy - adverse effects Malondialdehyde - urine Oxidative stress Oxidative Stress - drug effects Phenylethyl Alcohol - analogs & derivatives Phenylethyl Alcohol - pharmacology Rabbits |
title | A novel antioxidant agent caffeic acid phenethyl ester prevents shock wave-induced renal tubular oxidative stress |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-23T20%3A03%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20novel%20antioxidant%20agent%20caffeic%20acid%20phenethyl%20ester%20prevents%20shock%20wave-induced%20renal%20tubular%20oxidative%20stress&rft.jtitle=Urolithiasis&rft.au=Ozguner,%20Fehmi&rft.date=2005-06-01&rft.volume=33&rft.issue=3&rft.spage=239&rft.epage=243&rft.pages=239-243&rft.issn=0300-5623&rft.eissn=1434-0879&rft_id=info:doi/10.1007/s00240-005-0470-x&rft_dat=%3Cproquest_cross%3E2428279731%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c326t-3de9676d72e8a8c5a1c5f1af2b7d2c87226867531c7a7002f00d6fec2299c1803%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=884138397&rft_id=info:pmid/15877224&rfr_iscdi=true |